*Correspondence: Jing Yao, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
The frequency and extent of monitoring should be individualized based on patient-specific factors and the clinical indication for treatment
Cell Res (2018) 28:96980
BPC-157 can be part of a comprehensive optimization strategy by supporting recovery and reducing inflammation, but it is NOT a primary testosterone intervention
Like nasal sprays, capsules are non-invasive and appealing for regular use [10, 24, 26]
A randomized controlled trial published in the New England Journal of Medicine demonstrated that tesamorelin significantly reduced visceral adipose tissue in patients with abdominal fat accumulation (Falutz et al., 2007)
